Article

Radiomics-based prediction of treatment response to TRuC-T cell therapy in patients with mesothelioma: a pilot study

2024-02-07

Abstract excerpt

<title>Abstract</title> <p>T cell receptor fusion constructs (TRuCs), a next generation engineered T cell therapy, hold great promise. To accelerate the clinical development of these therapies, improving patient selection is a crucial pathway forward. We retrospectively analyzed 23 mesothelioma patients (85 target tumors) treated in a phase 1/2 single arm clinical trial (NCT03907852). Five imaging sites were invo...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 31421183-a584-54cf-9e99-21c2e17db083
DOI: 10.21203/rs.3.rs-3930436/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Radiomics-based prediction of treatment response to TRuC-T cell therapy in patients with mesothelioma: a pilot studyDOI 10.21203/rs.3.rs-3930436/v1Read

Current State of Art Therapy for MPM and Future Options Focus on ImmunotherapySemantic proximity Read

Patient-derived organoids from malignant pleural effusion to explore for alternative therapies in thoracic tumorsSemantic proximity Read

Gender differences in molecular-guided therapy recommendations for metastatic malignant mesothelioma.Semantic proximity Read

T cell receptor repertoire characteristics both before and following immunotherapy correlate with clinical response in mesotheliomaSemantic proximity Read

Molecular Mechanism of Tumor Progression and Novel Therapeutic and Diagnostic Strategies in MesotheliomaSemantic proximity Read

microRNA-497-5p-based screening identifies a novel synthetic lethal-type interaction via PKMYT1 and WEE1 in pleural mesotheliomaSemantic proximity Read

Towards a Survival Risk Prediction Model for Metastatic NSCLC Patients on Durvalumab Using Whole-Lung CT RadiomicsSemantic proximity Read

Durvalumab with platinum-pemetrexed for unresectable pleural mesothelioma: survival, genomic and immunologic analyses from the phase 2 PrE0505 trial.Semantic proximity Read

Omics Based Screening of novel inhibitors against malignant pleural mesotheliomaSemantic proximity Read

New approaches for mesothelioma: Biologics, vaccines, gene therapy, and other novel agentsSemantic proximity Read

Discordance in pleural mesothelioma response classification and modelling of impact on clinical trialsSemantic proximity Read

Intrapleural injection of Folactis promotes regression of malignant pleural effusion: a case of malignant pleural mesothelioma and the review of literaturesSemantic proximity Read